These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation? Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC Nucl Med Commun; 2016 Jan; 37(1):23-9. PubMed ID: 26440567 [TBL] [Abstract][Full Text] [Related]
3. Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match? Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM Ann Nucl Med; 2015 Feb; 29(2):132-7. PubMed ID: 25348549 [TBL] [Abstract][Full Text] [Related]
4. Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance. Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM Eur J Haematol; 2015 Jul; 95(1):83-9. PubMed ID: 25537478 [TBL] [Abstract][Full Text] [Related]
5. 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. Moog F; Bangerter M; Kotzerke J; Guhlmann A; Frickhofen N; Reske SN J Clin Oncol; 1998 Feb; 16(2):603-9. PubMed ID: 9469348 [TBL] [Abstract][Full Text] [Related]
6. Change of initial staging at early remission evaluation with FDG-PET/CT in Hodgkin lymphoma: a report of two cases. Molin D; Hagberg H; Suurküla M; Aström G Acta Oncol; 2010 May; 49(4):526-8. PubMed ID: 20397779 [No Abstract] [Full Text] [Related]
7. Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma. El-Galaly TC; d'Amore F; Mylam KJ; de Nully Brown P; Bøgsted M; Bukh A; Specht L; Loft A; Iyer V; Hjorthaug K; Nielsen AL; Christiansen I; Madsen C; Johnsen HE; Hutchings M J Clin Oncol; 2012 Dec; 30(36):4508-14. PubMed ID: 23150698 [TBL] [Abstract][Full Text] [Related]
8. Diffuse 18F-fluorodeoxyglucose accumulation in the bone marrow of a patient with haemophagocytic lymphohistiocytosis due to Hodgkin lymphoma. Harada S; Shinohara T; Naruse K; Machida H BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27793796 [No Abstract] [Full Text] [Related]
9. Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma. Adams HJ; Nievelstein RA; Kwee TC Blood Rev; 2015 Nov; 29(6):417-25. PubMed ID: 26113144 [TBL] [Abstract][Full Text] [Related]
11. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients. Chen-Liang TH; Martin-Santos T; Jerez A; Senent L; Orero MT; Remigia MJ; Muiña B; Romera M; Fernandez-Muñoz H; Raya JM; Fernandez-Gonzalez M; Lancharro A; Villegas C; Carlos Herrera J; Frutos L; Luis Navarro J; Uña J; Igua C; Sanchez-Vaño R; Cozar Mdel P; Contreras J; Sanchez-Blanco JJ; Perez-Ceballos E; Ortuño FJ Am J Hematol; 2015 Aug; 90(8):686-90. PubMed ID: 25925613 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of bone marrow involvement by FDG-PET for refractory Hodgkin lymphoma treated by unrelated allogeneic bone marrow transplantation]. Toubai T; Ota S; Onodera M; Baba U; Fujisawa F; Miura Y; Toyoshima N; Tanaka J; Asaka M; Imamura M Rinsho Ketsueki; 2003 Jul; 44(7):446-50. PubMed ID: 12931562 [TBL] [Abstract][Full Text] [Related]
13. Bone scanning and radiography in the evaluation of patients with malignant lymphoma. Jánoskuti L; Szilvási I; Papp G; Róna E; Benedek S; Fekete S Rofo; 1988 Oct; 149(4):427-8. PubMed ID: 2845515 [TBL] [Abstract][Full Text] [Related]
14. [Bone marrow disease revealed by leukocyte scintigraphy in a patient with relapsing fever of unknown origin]. Mortensen JC; Lindberg JA Ugeskr Laeger; 1994 Jun; 156(23):3503-4. PubMed ID: 8066869 [TBL] [Abstract][Full Text] [Related]
15. Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study. Pelosi E; Penna D; Douroukas A; Bellò M; Amati A; Arena V; Passera R; Bisi G Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):469-75. PubMed ID: 21150862 [TBL] [Abstract][Full Text] [Related]